ThinkstockBoston Scientific Corp. (NYSE: BSX) is trading higher today after earnings and after a restructuring direction has been set. Unfortunately for its investors, Boston Scientific remains a story of an endless turnaround…
U.S. equity markets opened mixed this morning on relatively little new data. In Europe, Italian consumer confidence rose more than expected and Germany auctioned 12-month bills at a positive yield for the…
These are some of the top analyst upgrades, downgrades and initiations seen in Wall St. research calls this Monday. Apple Inc. (NASDAQ: AAPL) reiterated Buy with $800 target and raised estimates at…
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall St. research calls this Tuesday. Amarin Corp. (NASDAQ: AMRN) started as Buy with $20 target at Citigroup.…
Are big mergers really worth it? After this week’s merger implosion news by Hewlett-Packard Co. (NYSE: HPQ), 24/7 Wall St. wanted to review and analyze many of the really bad mergers of…
The three major U.S. stock indexes opened lower this morning and really never got on track the entire day. The lower opening was likely a reaction to China’s weakest quarterly GDP growth…
The three major U.S. stock indexes opened lower this morning, and never really got untracked all day. Spanish 10-year bond yields fell 28 basis points to around 5.51%, while Spain again demurred…
Analyst calls often have many hidden gems in them, and sometimes the most interesting thing to take from these calls is what was not said. Credit Suisse came out this Tuesday with…
Medical device maker Boston Scientific (NYSE: BSX) has reported a second-quarter net loss of $3.40 billion, or $2.39 per diluted share. Adjusted earnings were $0.11 per share, which compares with $0.10 per…
Trey Thoelcke Thursday was D-Day for the Supreme Court decision on the Obama healthcare mandate as to its constitutionality. The long and short of it is that the mandate is constitutional as a tax…
Jon OggThese are some of today’s top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Tuesday. Achillion Pharmaceuticals Inc. (NASDAQ: ACHN) Started as Outperform with $11 target at Credit…
Ratings agency Moody’s has raised the debt rating of Boston Scientific Corp. (NYSE: BSX) from ‘Ba1’ to ‘Baa3’ with a stable outlook. The new rating applies to new senior unsecured debt and…
Paul Ausick All three major US stock indexes opened higher this morning, and spent the rest of the day bouncing around the neutral line. The reports from retailers on same-store sales in January were…
24/7 has compiled many of the predictions from various firms and various market pundits for what lies ahead in 2012. Wall St. modified analyst consensus price target methodology generates 12% expected upside…
Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street brokerage and research firms this Friday morning. AGCO Corporation (NYSE: AGCO) Maintained Outperform as Bull of…
